PATENT CLAIM ANALYSIS

Application Number: 15997310
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["514", "414000"]

Abstract:
The present specification provides a compound of formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an RORγ and/or RORγt mediated disease state.

Claim (Index 20):
The composition of  claim 17 , wherein (1R)-2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-(methylsulfonyl)-2,3-dihydro-1H-isoindole-1-carboxamide is present in an enantiomeric excess of at least about 98%.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.30556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15378360', '13294303', '13383611', '13383606', '13504209']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8324882647473758
- 35 USC 102 Novelty (BERT): 0.6308055954200426
- Combined Prediction Score: 0.8123199978146425
- Mean Citation Score: 412.0472199999999
- Max Citation Score: 630.9071
- Similarity Product: 512.2465734223723

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test